Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Rostedt Punga

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|March 11, 2020
Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAsAlyson A Fiorillo, Christopher R Heier, Yu-Fang Huang, et al.
Clinical Nuclear Medicine|November 27, 2024
Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PETSonja Kosek, Ellen Kilsved, Torsten Danfors, et al.
European Journal of Neurology|November 14, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and ControlsAmol K Bhandage, Sarah Hoffmann, Carla Dusemund, et al.
Muscle & Nerve|April 18, 2026
Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis (DIG-MG): A Randomized Controlled Trial of Feasibility, Adherence, and Effects on FatigueMaja Norling, Niclas Eriksson, Elisabet Westerberg, et al.
Journal of Neuroimmunology|October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravisLiis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 20, 2021
Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective studyRobert Frithiof, Elham Rostami, Eva Kumlien, et al.
Iscience|August 21, 2024
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controlsAmol K Bhandage, Viktorija Kenina, Yu-Fang Huang, et al.
European Journal of Neurology|February 6, 2024
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatmentNils Erik Gilhus, Henning Andersen, Linda Kahr Andersen, et al.
European Journal of Neurology|January 24, 2023
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"Andreas Meisel, Fulvio Baggi, Anthony Behin, et al.
European Journal of Neurology|September 12, 2022
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisalAndreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|March 11, 2020
Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAsAlyson A Fiorillo, Christopher R Heier, Yu-Fang Huang, et al.
Clinical Nuclear Medicine|November 27, 2024
Regional Metabolic Abnormalities in Autoimmune Encephalitis: A Meta-analysis of 498 Cases With Brain FDG PETSonja Kosek, Ellen Kilsved, Torsten Danfors, et al.
European Journal of Neurology|November 14, 2025
AXIN1, STAMBP, ST1A1, CDCP1, and SIRT2 Validated as Myasthenia Gravis Biomarkers: A Comparative Proteomic Study With MS, CIDP, and ControlsAmol K Bhandage, Sarah Hoffmann, Carla Dusemund, et al.
Muscle & Nerve|April 18, 2026
Digital Phenotyping and Lifestyle Intervention in Patients With Myasthenia Gravis (DIG-MG): A Randomized Controlled Trial of Feasibility, Adherence, and Effects on FatigueMaja Norling, Niclas Eriksson, Elisabet Westerberg, et al.
Journal of Neuroimmunology|October 15, 2018
Circulating microRNA plasma profile in MuSK+ myasthenia gravisLiis Sabre, Jeffrey T Guptill, Melissa Russo, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|April 20, 2021
Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective studyRobert Frithiof, Elham Rostami, Eva Kumlien, et al.
Iscience|August 21, 2024
Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controlsAmol K Bhandage, Viktorija Kenina, Yu-Fang Huang, et al.
European Journal of Neurology|February 6, 2024
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatmentNils Erik Gilhus, Henning Andersen, Linda Kahr Andersen, et al.
European Journal of Neurology|January 24, 2023
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"Andreas Meisel, Fulvio Baggi, Anthony Behin, et al.
European Journal of Neurology|September 12, 2022
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisalAndreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Pageof 9